Keyphrases
COVID-19
94%
Receptor-binding Domain
29%
Neutralizing Antibodies
25%
Spike Protein
16%
Monoclonal Antibody
16%
Coronavirus
15%
SARS-CoV-2 Variants
14%
Angiotensin-converting Enzyme 2 (ACE2)
13%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
12%
Variants of Concern
12%
Virus
12%
Severe Acute Respiratory Syndrome Coronavirus 2 Variants
11%
B Cells
11%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
11%
Antibody Response
9%
Vesicular Stomatitis Virus
9%
SARS-CoV-2 Infection
8%
Nanoparticle Vaccine
8%
Antibody Targeting
8%
COVID-19 Pandemic
7%
MRNA Vaccine
7%
Omicron Variant
7%
Mouse Hepatitis Virus
7%
Miniprotein
6%
Intranasal
6%
N-terminal Domain
6%
Neutralizing Monoclonal Antibody
6%
Human Antibody
6%
Binding Residues
6%
Ferritin Nanoparticles
6%
Insulin
6%
Chimpanzee Adenovirus
5%
Weight Loss
5%
SARS-CoV-2 Spike Protein
5%
Broad-spectrum Antivirals
5%
Neutralizing Activity
5%
Non-structural Protein 14
5%
Upper Respiratory Tract
5%
Replication-competent
5%
Exoribonuclease
5%
Viral Burden
5%
BA.1
5%
SARS-CoV-2 Omicron
5%
Broad Neutralization
5%
Serological Assay
5%
Exon
5%
SARS-CoV-2 Receptor Binding Domain
5%
SARS-CoV-2 Replication
5%
GS-5734
5%
Bruton's Tyrosine Kinase
5%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Spike
34%
Neutralizing Antibody
32%
Receptor Binding
31%
Neutralization
23%
Monoclonal Antibody
19%
Omicron Coronavirus Variant
14%
Coronavirinae
14%
Virus
13%
SARS Coronavirus
13%
B Cell
13%
Immunity
11%
Epitope
11%
COVID-19
10%
Coronavirus
10%
Murine Hepatitis Virus
10%
Antibody Response
7%
Angiotensin
7%
Amino Terminal Sequence
6%
Insulin
6%
Severe Acute Respiratory Syndrome
6%
Ferritin
6%
Innate Immune System
5%
Viral Replication
5%
Viral Load
5%
Bruton Tyrosine Kinase
5%
Exon
5%
Titer
5%
Human Monoclonal Antibody
5%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
50%
Infection
24%
B Cell
9%
Neutralizing Antibody
9%
Coronavirus
9%
Diseases
9%
Receptor Binding
8%
COVID-19
8%
Coronavirinae
7%
Virus
7%
Antivirus Agent
7%
Lung
6%
Monoclonal Antibody
6%
SARS Coronavirus
6%
Exoribonuclease
5%
Bruton Tyrosine Kinase
5%